6/1/2021 7:12:03 AM
Myriad Genetics Completes Sale Of Myriad MyPath Melanoma Laboratory To Castle Biosciences For $32.5 Mln Cash
5/24/2021 7:09:06 AM
Myriad Genetics Signs Definitive Agreement To Sell Myriad RBM To Q2 Solutions
5/20/2021 7:37:21 AM
Myriad Genetics Names Melissa Gonzales President Of Its Women's Health Business
5/3/2021 4:08:18 PM
Myriad Genetics March Quarter GAAP Loss/Shr $0.52 Vs Loss $1.55 Last Year
5/3/2021 7:16:41 AM
Myriad Genetics Expects To Be Profitable By Q4'21
5/3/2021 7:13:52 AM
Myriad Genetics Agrees To Sell Myriad Autoimmune's Vectra Testing Business To Labcorp
4/27/2021 7:08:10 AM
Myriad Genetics To Sell Myriad MyPath Melanoma, LLC, Laboratory
3/2/2021 7:19:41 AM
Myriad Genetics Announces Precision Oncology Collaboration With Intermountain Precision Genomics
2/23/2021 4:09:13 PM
Myriad Genetics Q4 GAAP Loss/Shr $0.59 And Adjusted Loss/Shr $0.12
1/19/2021 7:15:41 AM
Myriad Genetics Gets Reimbursement For BRACAnalysis Diagnostic System In Japan
1/8/2021 7:09:21 AM
Myriad Genetics Receives First Reimbursement Decision For Myriad MyChoice Diagnostic System
9/10/2020 7:33:24 AM
Myriad Genetics Adds Rashmi Kumar To Board